Bibliografías temáticas / NSCLP / Libros

Libros sobre el tema "NSCLP"

Siga este enlace para ver otros tipos de publicaciones sobre el tema: NSCLP.
Autor: Grafiati
Publicado: 11 de marzo de 2023

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte los 25 mejores mejores libros para su investigación sobre el tema "NSCLP".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Explore libros sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.

1

U.S. Army Chemical Materiel Destruction Agency., ed. Non-Stockpile Chemical Materiel Program: NSCMP. [Aberdeen Proving Ground, MD: U.S. Army Chemical Materiel Destruction Agency, 1995.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

U.S. Army Chemical Materiel Destruction Agency., ed. Non-Stockpile Chemical Materiel Program: NSCMP. [Aberdeen Proving Ground, MD: U.S. Army Chemical Materiel Destruction Agency, 1995.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

U.S. Army Chemical Materiel Destruction Agency, ed. Non-Stockpile Chemical Materiel Program: NSCMP. [Aberdeen Proving Ground, MD: U.S. Army Chemical Materiel Destruction Agency, 1995.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

U.S. Army Chemical Materiel Destruction Agency, ed. Non-Stockpile Chemical Materiel Program: NSCMP. [Aberdeen Proving Ground, MD: U.S. Army Chemical Materiel Destruction Agency, 1995.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Cappuzzo, Federico. Guide to Targeted Therapies: EGFR mutations in NSCLC. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-03059-3.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Kim, Ho-jung. array-CGH rŭl iyong han piso sepʻo pʻyeam ŭi chogi chaebal pʻyojija mit chindan mohyŏng kaebal =: Development of early-recurrence detection marker and diagnostic model using array-CGH in NSCLC. [Seoul]: Pogŏn Pokchibu, 2007.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Cappuzzo, Federico. Guide to Targeted Therapies : EGFR mutations in NSCLC: EGFR mutations in NSCLC. Adis, 2014.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Non-Stockpile Chemical Materiel Program: NSCMP. [Aberdeen Proving Ground, MD: U.S. Army Chemical Materiel Destruction Agency, 1995.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Krawczyk, Paweł Adam, Qing Zhou, Rafal Dziadziuszko y Natasha Leighl, eds. Issues and Challenges in NSCLC Immunotherapy. Frontiers Media SA, 2021. http://dx.doi.org/10.3389/978-2-88971-816-0.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Northumberland Strait Crossing Project (NSCP). [Washington, DC]: Federal Highway Administration, 1996.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
11

Huang, Meijuan, Hongbo Hu, Qian Chu, Yanyan Lou y Yong He, eds. Immunotherapy for NSCLC with Oncogenic Driver Variants. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-83250-306-5.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
12

Cassidy, Jim, Donald Bissett, Roy A. J. Spence OBE, Miranda Payne, Gareth Morris-Stiff y Madhumita Bhattacharyya. Breast cancer. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199689842.003.0014_update_001.

Texto completo
Resumen
Thoracic cancer examines the epidemiology, aetiology, and role of screening and prevention in the reduction of deaths from lung cancer, the majority caused by cigarette smoking. The pathology and genetics of lung cancer, with particular note of the driver mutations, are followed by the symptoms and signs of the disease. Appropriate investigations are described to stage the tumour. The optimum treatment for localised non-small cell lung cancer (NSCLC) is surgical resection, followed in some cases by adjuvant chemotherapy. However, most cases present with disease too advanced for surgery, and for these chemotherapy and radiotherapy are appropriate. Metastatic NSCLC can be treated with platinum based doublet chemotherapy with modest palliative benefits. Metastatic NSCLC with specific driver mutations are amenable to control by targeted therapy. Locally advanced NSCLC is often treated with similar chemotherapy and radiotherapy, ideally administered concurrently, to achieve symptom relief but also improved survival rates. Short course simple radiotherapy offers symptom relief in patients not fit for chemotherapy. Patients with localised NSCLC who are not fit for surgery, may benefit from radical radiotherapy, particularly stereotactic radiotherapy. Small cell lung cancer (SCLC) is characterised by almost universal systemic spread, so that surgery is rarely appropriate. Staging is similar to NSCLC, and chemotherapy is the mainstay of treatment, usually cisplatin or carboplatin combined with etoposide. When possible, this is combined with concurrent thoracic irradiation covering all radiological sites of disease. Prophylactic cranial irradiation reduces the risk of CNS disease. Malignant pleural mesothelioma is caused by occupational asbestos exposure. Symptoms and signs, investigation and staging, and management are discussed. Thymic tumours, their pathology, presenting symptoms including paraneoplastic syndromes, investigation, staging and treatment are reviewed.
Los estilos APA, Harvard, Vancouver, ISO, etc.
13

Cappuzzo, Federico. Guide to Targeted Therapies: Egfr Mutations in Nsclc. Springer International Publishing AG, 2014.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
14

Cappuzzo, Federico. Guide to Targeted Therapies: EGFR Mutations in NSCLC. Springer, 2014.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
15

Troncone, Giancarlo, Julia Rotow, Parneet Cheema y Pasquale Pisapia. Fast Facts: EGFR Exon 20 Insertion Mutations in NSCLC. Karger AG, S., 2022.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
16

Faber, Anthony. Overcoming Resistance to EGFR Inhibitors in EGFR Mutant NSCLC. Elsevier Science & Technology Books, 2021.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
17

Troncone, Giancarlo, Julia Rotow, Parneet Cheema y Pasquale Pisapia. Fast Facts: EGFR Exon 20 Insertion Mutations in NSCLC. Karger AG, S., 2022.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
18

Faber, Anthony. Overcoming Resistance to EGFR Inhibitors in EGFR Mutant NSCLC. Elsevier Science & Technology, 2022.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
19

Malapelle, Umberto, Etienne Giroux Leprieur, Christian Rolfo, Paul Takam Kamga y Marius Tresor Chiasseu, eds. Emerging Biomarkers for NSCLC: Recent Advances in Diagnosis and Therapy. Frontiers Media SA, 2021. http://dx.doi.org/10.3389/978-2-88966-915-8.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
20

Erridge, Sara C., Elizabeth Toy y Sorcha Campbell. Radiotherapy for thoracic tumours. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199696567.003.0005.

Texto completo
Resumen
Chapter 5 discusses two main subtypes of lung cancer; small cell (SCLC) and non-small cell (NSCLC). However, the management is becoming increasingly similar so the general principles of lung cancer radiotherapy will be discussed first, followed by the specific features of management of the two pathological entities.
Los estilos APA, Harvard, Vancouver, ISO, etc.
21

Sun, Shi-Yong y Chunxia Su, eds. Challenges and Opportunities of TKIs in the Treatment of NSCLC Patients With Uncommon Mutations. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88976-866-0.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
22

Parikh, Ravi B. Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer (NSCLC). 2014.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
23

Hirsh, Vera y Barbara Melosky, eds. The Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine. Frontiers Media SA, 2015. http://dx.doi.org/10.3389/978-2-88919-543-5.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
24

Mohamed, Sherif. Cell Cycle-Related Proteins in Mediastinal Lymph Nodes of Patients with N2-Nsclc Obtained by Ebus-Tbna. Independently Published, 2018.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
25

Hirsh, Vera y Barbara Melosky, eds. Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine. Frontiers Media SA, 2018. http://dx.doi.org/10.3389/978-2-88945-397-9.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
También puede estar interesado en las bibliografías sobre el tema "NSCLP" para otros tipos de fuentes:
Artículos de revistas Tesis
Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!

Pasar a la bibliografía